Overview & Mechanism
A stabilized analogue of growth hormone-releasing hormone (GHRH) that stimulates the pituitary to secrete endogenous, pulsatile growth hormone, raising IGF-1.
Research Dosage
2 mg/day
Subcutaneous injection
Once daily
6+ months
Reconstitution & Storage
Reconstitute per kit instructions with provided diluent. Best administered in the evening.
Lyophilized: refrigerate 2–8 °C. Reconstituted: use per manufacturer (typically within 24 hours or refrigerated per label).
Safety & Side Effects
Injection-site reactions common. May cause joint pain, flushing, or edema. Monitor IGF-1.
Studies
Tesamorelin for HIV lipodystrophy
Tesamorelin 2 mg/day significantly reduced visceral adipose tissue and improved triglycerides in HIV patients with lipodystrophy over 26 weeks.
Read studyReferences
Research Use Only
This information is intended for licensed researchers and educational purposes only. It does not constitute medical advice. PureLife Health products are not approved for human use by Health Canada or the FDA. Always consult a qualified medical professional and verify against current literature.